Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo controlled randomized trial in healthcare workers.
Polo R, García-Albéniz X, Terán C, Morales M, Rial-Crestelo D, Garcinuño MA, García Del Toro M, Hita C, Gómez-Sirvent JL, Buzón L, Díaz de Santiago A, Pérez Arellano JL, Sanz J, Bachiller P, Martínez Alfaro E, Díaz-Brito V, Masiá M, Hernández-Torres A, Guerra J, Santos J, Arazo P, Muñoz L, Arribas JR, Martínez de Salazar P, Moreno S, Hernán MA, Del Amo J; EPICOS; EPICOS investigator team, Del Amo J, Rosa Polo, Moreno S, Berenguer J, Martínez E, Hernán M, Martínez de Salazar P, García de Albéniz X; Collaborators; Data safety monitoring board; Contract Research Organization; Participating hospitals.
Polo R, et al.
Clin Microbiol Infect. 2022 Aug 5:S1198-743X(22)00370-6. doi: 10.1016/j.cmi.2022.07.006. Online ahead of print.
Clin Microbiol Infect. 2022.
PMID: 35940567
Free PMC article.